IE
DTIL icon

Israel Englander’s Precision BioSciences DTIL Stock Holding History

Israel Englander’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-27,684
Closed -$152K – 5981
2026
Q1 		$152K Buy
+27,684
New +$128K ﹤0.01% 5253
2025
Q2 		– Sell
-65,586
Closed -$313K – 5957
2025
Q1 		$313K Buy
+65,586
New +$334K ﹤0.01% 5081
2024
Q1 		– Sell
-7,793
Closed -$85.3K – 6262
2023
Q4 		$85.3K Sell
7,793
-1,996
-20% -$21.5K ﹤0.01% 5379
2023
Q3 		$100K Buy
9,789
+426
+5% +$6.55K ﹤0.01% 5339
2023
Q2 		$148K Sell
9,363
-67,128
-88% -$1.53M ﹤0.01% 5228
2023
Q1 		$1.73M Sell
76,491
-36,176
-32% -$1.19M ﹤0.01% 3578
2022
Q4 		$4.02M Sell
112,667
-28,380
-20% -$1.12M ﹤0.01% 2998
2022
Q3 		$5.5M Buy
141,047
+89,906
+176% +$4.27M ﹤0.01% 2801
2022
Q2 		$2.46M Buy
51,141
+37,315
+270% +$2.19M ﹤0.01% 3487
2022
Q1 		$1.28M Sell
13,826
-2,625
-16% -$357K ﹤0.01% 4302
2021
Q4 		$3.65M Buy
16,451
+5,356
+48% +$1.5M ﹤0.01% 3199
2021
Q3 		$3.84M Sell
11,095
-6,014
-35% -$2.04M ﹤0.01% 3185
2021
Q2 		$6.43M Sell
17,109
-30
-0.2% -$9.01K ﹤0.01% 2428
2021
Q1 		$5.32M Sell
17,139
-1,967
-10% -$689K ﹤0.01% 2502
2020
Q4 		$4.78M Buy
19,106
+14,578
+322% +$3.57M ﹤0.01% 2488
2020
Q3 		$837 Sell
4,528
-18,461
-80% -$3.67M ﹤0.01% 3253
2020
Q2 		$5.75M Buy
22,989
+17,523
+321% +$3.84M 0.01% 1629
2020
Q1 		$989K Buy
+5,466
New +$1.43M ﹤0.01% 2474
2019
Q4 		– Sell
-450
Closed -$113K – 4299
2019
Q3 		$113K Buy
+450
New +$146K ﹤0.01% 3947
2019
Q2 		– Sell
-5,717
Closed -$3.08M – 4122
2019
Q1 		$3.08M Buy
+5,717
New +$3.03M ﹤0.01% 2104

Other funds holding DTIL

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Israel Englander's DTIL Position: Q2 2026 in Review

Israel Englander sold out of Precision BioSciences (DTIL) in Q2 2026, closing a stake of 27,684 shares — an estimated $152K sold.

Israel Englander first reported a position in DTIL in Q1 2019 and held it in 20 quarters. The position peaked at $6.43M in Q2 2021. 94 funds tracked by Wall St. Rank hold DTIL as of Q2 2026.

  • Israel Englander reported no remaining Precision BioSciences position as of Q2 2026 after selling out during the quarter.
  • Israel Englander sold 27,684 Precision BioSciences shares in Q2 2026, an estimated $152K.
  • Israel Englander first reported a position in Precision BioSciences in Q1 2019 and held it in 20 quarters.
  • Israel Englander's Precision BioSciences position peaked at $6.43M in Q2 2021.
  • 94 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.